Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • Biotechnology
  • After one failed acquisition attempt, Lisata finds lifeline in Marea merger

After one failed acquisition attempt, Lisata finds lifeline in Marea merger

September 17, 2026Posted inBiotechnology

After a failed merger that led to massive layoffs and a lawsuit, solid tumor biotech Lisata Therapeutics has found a new future through a merger with cardio specialist Marea Therapeutics.

Post navigation

Previous Post
Roche signs $1B deal with Dualitas to pair up on big bispecific screening drive
Next Post
DPHARM: How to address the clinical trial enrollment crisis?

Recent Posts

  • Sentira Brings Claude’s AI to 10x Genomics’ Chromium Platform
  • FDA Delays PDUFA Action on Agios’ Mitapivat sNDA for SCD
  • StockWatch: Gene Editing Shares Jump on ESGCT Data, FDA Draft Guidance
  • Opentrons Raises $40M in Series E to Expand Its Robotics, Software, Data Infrastructure
  • 100 Million-Cell AI-Ready Dataset with Single-Cell and Proteomic Data Created by Parse and Nomic

Archives

  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • September 2024
  • August 2024
  • March 2024
  • September 2023

Privacy Policy    Terms

Scroll to Top